Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Water Science and Technology : a Journal of the International Association on Water Pollution Research|December 20, 2011
Treatment of biologically treated leachate by oxidation and coagulationH Y Zhang, Y C Zhao, J Y QiZhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|March 9, 2021
[Analysis of diagnostic value of UGT1A1 gene detection in Gilbert syndrome]M Zhang, W N Li, G Chen, et al.[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|April 17, 2017
[Long-term outcomes after cataract surgery in infants with congenital cataract]J Y Qi, W Xiao, M Y Wang, et al.Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|May 28, 2018
[Current epidemiological status of causes of disease among patients with liver disease hospitalized in Department of Infectious Diseases in a large general hospital within the past 20 years]R H Zhao, K Ma, J Hu, et al.World Journal of Gastroenterology|April 5, 2016
Short- and long-term effect of interferon therapy for chronic hepatitis CZ Y Tang, J Y Qi, H X Shen, et al.The Journal of Physical Chemistry. A|November 14, 2008
Density functional theory study of CsC(n)- (n = 1-10) clustersJ Y Qi, L Dang, M D Chen, et al.Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 27, 2021
[Analysis on disease burden of stroke in China and the regions with different sociodemographic index from 1990 to 2017]J Y Qi, C R Wang, M Liu, et al.Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao|January 1, 1993
Establishment and application of SPA-co-operated ELISA for detection of anti-HCV-IgMF H Li, L S Guo, Z Q Yu, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016
[Chronic neutrophilic leukemia complicated with multiple myeloma: two cases report and literature review]B Jiang, J Y Qi, Q H Li, et al.Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2018
[Tolerance and pharmacodynamics phase Ⅰ clinical trial study of chimeric anti-CD20 monoclonal antibody IBI301 in Chinese patients with CD20-positive non-Hodgkin's lymphoma]B Jiang, J Y Qi, M Y Sun, et al.Pageof 2